PRDX5 and head and neck cancer: NADPH-dependent selenoprotein thioredoxin reductase (TrxR) is often overexpressed in cancer [39, 55], which associates with poor survival of patients with different types of cancer, including breast, lung, pancreatic, prostate, and head and neck cancers [39].